Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prochymal for Acute GVHD
NCT00136903Phase 2Completed
- Sponsor
- Mesoblast Ltd
- Start
- Apr 2005
- Primary completion
- Jul 2006
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of remestemcel-L-rknd in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Mesoblast Ltd. Started Apr 2005; status: completed.
02
Drugs
remestemcel-L-rknd
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT00136903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136903.